{"id":13418,"date":"2018-06-12T16:00:39","date_gmt":"2018-06-12T14:00:39","guid":{"rendered":"http:\/\/newsite.andrewalliance.com\/?p=13418"},"modified":"2022-10-03T02:28:56","modified_gmt":"2022-10-03T00:28:56","slug":"series-c-financing","status":"publish","type":"post","link":"https:\/\/www.andrewalliance.com\/fr\/press\/series-c-financing\/","title":{"rendered":"Andrew Alliance Raises $14M From Top Life Sciences Industry Partners and Global Investors"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n

Liquid Handling Robotics Company Closes Series C;
\nWill Fund Continued Innovation in Improving Lab Results and Repeatability<\/p>\n<\/div>\n

\n

GENEVA (June 12, 2018)<\/strong>\u00a0\u2014 Andrew Alliance S.A., the robotics company that is improving repeatability with an innovative approach to liquid handling with conventional laboratory pipettes, today announced a $14 million investment by several of the leading life sciences enterprises, including Tecan Group, the Waters Corporation, Inpeco, Rancilio Cube, Sam Eletr Trust and Omega Funds.<\/p>\n<\/div>\n

\n

The C-round investment brings together a strategic mix of globally recognized life sciences market leaders, along with private equity investors and including existing investors.<\/p>\n

\u201cWe are delighted to expand our team of investors and partners with the industry\u2019s most recognized companies,\u201d said Piero Zucchelli, CEO and a co-founder of Andrew Alliance. \u201cIt\u2019s particularly meaningful that both Tecan and Waters appreciate how we\u2019re making robotics accessible to more scientists.\u201d<\/p>\n<\/div>\n

\n

The Tecan Group is the world leader for automated liquid handling solutions, and Waters has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. Both companies are considered technology leaders in their respective fields.<\/p>\n

\u201cAndrew Alliance\u2019s robot changes the game for repeatability \u2013 and further improves our customers\u2019 operational efficiency,\u201d said Paul Tardif, senior director of corporate development at Waters. \u201cThe Andrew robots are extraordinarily affordable and solve a persistent problem. Our customers are eager for a ready-to-use solution like this.\u201d<\/p>\n

In just four years, Andrew Alliance has become the leading choice for life science bench robotics. It\u2019s relied on by 18 of the top 20 pharmaceutical companies, the top four diagnostic companies and 16 of the top 20 of the world\u2019s leading academic research institutions.<\/p>\n<\/div>\n

\n

Andrew Alliance\u2019s flagship offering is a family of flexible, software-driven robot models, each with a footprint about the size of a standard piece of paper. The robots work right out of the box and deliver absolute consistency in how liquids are measured and tested, using standard pipettes and consumables. Andrew performs its job within a few minutes of setup.<\/p>\n

\u201cAndrew Alliance\u2019s affordable benchtop robots using conventional pipettes are a new and complementary approach to Tecan\u2019s workstations, which help customers to automate a wide variety of laboratory workflows in research and clinical diagnostics,\u201d said David Martyr, CEO of Tecan.<\/p>\n<\/div>\n

\n

Andrew Alliance will use the funds for continuous product innovation and strategic industry partnerships. It also will extend its close collaboration with customers worldwide to refine future offerings.<\/p>\n

\u201cDemand for better reproducibility continues to increase,\u201d said Otello Stampacchia, managing director and founder of Omega Funds, an early investor.<\/p>\n

\u201cThe ongoing innovation in life science creates a vast opportunity for new automated tools and approaches like Andrew\u2019s robots,\u201d said Sam Eletr, a member of the founding team and an early investor.<\/p>\n<\/div>\n

\n

About Andrew Alliance<\/strong><\/p>\n

Andrew Alliance is advancing science with a new class of high-performance, easy-to-use robots that dramatically improve the repeatability, performance and speed of liquid handling. This new approach, and Andrew, the flagship robot, are winning awards and rapidly transforming bench research in hundreds of pharmaceutical, diagnostic and academic laboratories worldwide, by eliminating routine pipetting errors and time-consuming manual efforts. Visit\u00a0andrewalliance.com<\/a>\u00a0to see how it works.<\/p>\n<\/div>\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
June 12th, 2018|<\/span>press release<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Andrew Alliance today announced a $14 million investment by several of the leading life sciences enterprises, including Tecan Group, the Waters Corporation, Inpeco, Rancilio Cube, Sam Eletr Trust and Omega Funds.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-13418","post","type-post","status-publish","format-standard","hentry","category-press"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts\/13418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/comments?post=13418"}],"version-history":[{"count":0,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts\/13418\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/media?parent=13418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/categories?post=13418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/tags?post=13418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}